Hikma receives FDA approval for its generic VascepaÂ®

Corporate Breaking News

Home : Hikma receives FDA approval for its generic VascepaÂ®

May 22 2020	Hikma receives FDA approval for its generic VascepaÂ®
LONDON, May 22, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, today announces that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA Inc. has received approval from the US Food and Drug Administration (FDA) for its...


Source:https://www.prnewswire.com:443/news-releases/hikma-receives-fda-approval-for-its-generic-vascepa-301064061.html

Related News
» Scott Pink, Special Counsel, O'Melveny & Myers LLP to Speak at TKG’s The HIPAA Privacy Rule and COVID-19: Trends, Developments, Compliance Issues » Mayne Pharma launches BAC 300 capsules in the United States